Genmab — Marts 2020
-
Det er nok Nasdaq igen.
-
News: GENMAB A/S <GMAB.CO>: BARCLAYS RAISES PRICE TARGET TO DKK 1700 FROM DKK 1650 - RTRS | News Wires | Thomson Reuters Eikon
-
Er det ikke altid sådan, når man er i "jeres" alder Pensionisten?

-
Gilead køber amerikansk kræftselskab for 33 mia. kr.
Gilead Sciences betaler 33 mia. kr. for at opkøbe det amerikanske biotekselskab Forty Seven, der arbejder på flere antistoffer mod kræft. Sidstnævntes aktie stiger voldsomt.
(medwatch.dk)
-
DAX har også rettet sig markant den sidste time
Fut fut!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind